Generate a tailored SOP for Dr. Nicholas Blondin. Improve your application with a focused, well-structured draft.
Nicholas Blondin is an Associate Professor in the Department of Neurology at Yale School of Medicine. He specializes in treating both benign and malignant brain tumors, including glioblastoma and IDH-mutant glioma. Dr. Blondin completed his medical degree at the University of Connecticut School of Medicine and underwent residency in neurology at Yale New Haven Hospital, where he served as Chief Resident. He also completed a fellowship in Neuro-Oncology at Yale. His clinical expertise particularly emphasizes the management of neurological symptoms arising from cancer, such as seizures, cognitive dysfunction, and headaches. In addition to patient care, Dr. Blondin leads the Neuro-Oncology Clinical Research Team at Yale, where he is involved as a Principal Investigator in several clinical trials exploring innovative treatments for brain tumors. He has been recognized for his contributions to the field and is an active member of both the Developmental Therapeutics section at Yale Cancer Center and the Yale Biomedical Imaging Institute.
Yale School of Medicine • New Haven, CT
Associate Professor in the Department of Neurology focusing on Neuro-Oncology.
Yale Cancer Center • New Haven, CT
Leads research efforts on clinical trials related to brain tumor treatments.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.